Houston-based Coterra Energy Inc. (CTRA) is a diversified energy company engaged in the exploration, development, and production of oil, natural gas, and natural gas liquids. With a market cap of $18.5 billion, Coterra operates in key regions like the Permian Basin, Marcellus Shale, and Anadarko Basin, showcasing its strong presence in the energy sector.
The energy major has notably underperformed the broader market over the past year. CTRA stock has dropped 4.9% on a YTD basis and 5.5% over the past 52 weeks, lagging behind the S&P 500 Index’s ($SPX) 8.2% surge in 2025 and 17% gains over the past year.
Looking closer, Coterra has also lagged behind the Energy Select Sector SPDR Fund’s (XLE) 2.4% uptick in 2025 but matched XLE’s 5.5% drop over the past 52 weeks.
Coterra Energy’s stock prices plunged 9.3% in the trading session after the release of its Q1 results on May 5. Driven by a notable growth in oil and natural gas revenues, its overall topline for the quarter surged 32.9% year-over-year to $1.9 billion. However, this figure missed the consensus estimates by a notable margin. Furthermore, due to macroeconomic uncertainty and oil price headwinds, Coterra lowered its Permian investment guidance from its previous outlook, unsettling investor confidence.
On a positive note, Coterra delivered a 58.7% growth in adjusted net income to $608 million, exceeding Street expectations.
For the full fiscal 2025, ending in December, analysts expect CTRA to deliver an adjusted EPS of $2.47, marking a 53.4% growth year-over-year. The company has a mixed earnings surprise history. While it has surpassed the Street’s bottom-line estimates twice over the past four quarters, it has missed the projections on two other occasions.
The stock maintains a consensus “Strong Buy” rating overall. Of the 23 analysts covering the stock, opinions include 16 “Strong Buys,” two “Moderate Buys,” and five “Holds.”
This configuration is slightly less bullish than a month ago, when 17 analysts gave “Strong Buy” recommendations.
On Jul. 17, Piper Sandler analyst Mark Lear reiterated an “Overweight” rating on CTRA, while setting a price target of $37.
CTRA’s mean price target of $33.39 suggests a 37.5% upside from current price levels, while the Street high target of $38 represents a staggering 56.4% premium.
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
